🇺🇸 FDA
Pipeline program

Olanzapine

Huiai 2014Y2-00105

Unknown small_molecule active

Quick answer

Olanzapine for Schizophrenia is a Unknown program (small_molecule) at Guangzhou Psychiatric Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Guangzhou Psychiatric Hospital
Indication
Schizophrenia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials